PNW vs RNA · P/E 19, rev $2.61B vs rev $22.6M
Pinnacle West Capital Corp (PNW) versus Atrium Therapeutics, Inc. Common Stock (RNA) — a side-by-side from cached financials, not a winner call.
Pinnacle West Capital Corp (PNW) is a utilities - regulated electric company listed on NYSE.
Atrium Therapeutics, Inc. Common Stock (RNA) is a biotechnology company listed on NASDAQ.
Latest reported PNW revenue for 2026-06-30 was $2.61B. Net income was $215.9M. PNW currently screens at market cap $12.41B and trailing P/E 19.1.
Latest reported RNA revenue for 2026-06-30 was $22.6M. Net income was -$36.8M. Revenue was up 15.3% from 2026-03-31 to 2026-06-30. RNA currently screens at market cap $217.5M.
PNW currently screens at market cap $12.41B and trailing P/E 19.1. RNA currently screens at market cap $217.5M.
Not investment advice. Open the PNW and RNA stock pages for the full models.
Not investment advice.